Ripple kopen? Dit zijn de mogelijkheden

Becton, Dickinson & Aandeel

253,06USD -0,77USD -0,30%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Becton, Dickinson & Co. (BD) - Profiel

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Aandeelhouder

Eigenaar in %
Freefloat99,70
T. Rowe Price Associates, Inc. (Investment Management)12,65
The Vanguard Group, Inc.8,20
Fidelity Management & Research Co.6,29
BlackRock Fund Advisors4,64
SSgA Funds Management, Inc.4,24
Fundsmith LLP1,40
Franklin Advisers, Inc.1,33
Geode Capital Management LLC1,24
Northern Trust Investments, Inc.(Investment Management)1,20
JPMorgan Investment Management, Inc.1,11
Fiera Capital Corp. (Investment Management)1,10
Wells Fargo Clearing Services LLC0,98
Putnam Investment Management LLC0,86
Norges Bank Investment Management0,85

Adres

1 Becton Drive, 07417-1880 Franklin Lakes
Postbus:
Telefoon: 12018476800
Fax: 12018474845
Internet: http://www.bd.com

Management

Patricia A. Walesiewicz
Assistant Secretary
Vincent A. Forlenza, MBA
Chairman & Chief Executive Officer
Charles R. Bodner
Chief Accounting Officer & Senior VP-Finance
Aaron Pettit
Chief Ethics & Compliance Officer, Senior VP
Christopher R. Reidy MBA, CPA
Chief Financial Officer, CAO & EVP-Administration
Betty D. Larson, MBA
Chief Human Resources Officer
Richard Pierle
Chief Information Officer & Executive VP
David W. Highet
Chief Intellectual Property Counsel & VP
George J. Parr
Chief Marketing Officer & Executive Vice President
William R. Sigmund, MD
Chief Medical Officer & EVP
Pierre Boisier
Chief Quality Officer & Executive Vice President
Linda J. Peters
Chief Regulatory Officer & Executive VP
John A. DeFord, PhD
Chief Technology Officer & Executive VP
Patrick K. Kaltenbach
Executive VP & President-Life Sciences Segment
Linda M. Tharby
Executive Vice President-Customer Experience
Samrat S. Khichi, MBA
General Counsel & Executive Vice President
Kristen L. Cardillo
Head-Corporate Communications
Troy Kirkpatrick
Head-Media Relations
Marshall O. Larsen
Independent Director
Catherine M. Burzik
Independent Director
Bertram L. Scott
Independent Director
Christopher Ian Montague Jones
Independent Director
Rebecca W. Rimel, MBA
Independent Director
Timothy M. Ring
Independent Director
Jeffrey William Henderson
Independent Director
Robert Andrew Eckert, MBA
Independent Director
Claire M. Fraser-Liggett, PhD
Independent Director
David F. Melcher, MBA
Independent Director
Claire Pomeroy MD, MBA
Independent Director
Thomas E. Polen, MBA
President & Chief Operating Officer
Alexandre Conroy
President-Europe, EMA & American Region
Gary DeFazio
Secretary & Senior Vice President
Antoinette F. Segreto
Senior Vice President-Tax
John E. Gallagher
Treasurer & CFO-Medical Segment
Monique N. Dolecki
Vice President-Investor Relations

Invoer toevoegen